Dynamic three-dimensional-cardiac magnetic resonance (3D-CMR) perfusion proved highly diagnostic for the detection of angiographically defined coronary artery disease (CAD) and has been used to assess the efficacy of coronary stenting procedures. The present study aimed to relate significant coronary lesions as assessed by fractional flow reserve (FFR) to the volume of myocardial hypoenhancement on 3D-CMR adenosine stress perfusion imaging and to define the inter-study reproducibility of stress inducible 3D-CMR hypoperfusion.
Introduction
Cardiac magnetic resonance (CMR) imaging enables non-invasive assessment of myocardial perfusion in patients with known and suspected coronary artery disease (CAD). 1 -5 Two-dimensional multislice CMR perfusion techniques yield high diagnostic accuracy, but the limited spatial coverage does not permit quantification of ischaemic tissue volume to guide therapy as recommended by the recent European guidelines on myocardial revascularization. 6 Therefore, radiation-based nuclear imaging methods have become the methods of choice for quantifying ventricular ischaemia. 7, 8 Besides exposure of the patient with ionizing radiation, the limited spatial resolution provided by single photon and positron emission tomography may be regarded as a drawback particularly when aiming at the detection of subendocardial ischaemic reactions. In order to address the limited, non-contiguous coverage of two-dimensional, multislice CMR perfusion techniques, threedimensional (3D-CMR) methods have been developed. 9 -11 Whole-heart coverage is achieved by employing data under sampling strategies in conjunction with appropriate image reconstruction techniques. 12 In a particular implementation, dynamic 3D-CMR perfusion imaging utilizes under-sampling in k-space and time (k-t) including sensitivity encoding (SENSE). 11, 13, 14 This approach proved highly diagnostic for the detection of angiographically defined CAD based on quantitative angiographic measurements and has been successfully employed to assess the efficacy of coronary stenting procedures using volumetry of myocardial hypoenhancement. 15 However, quantitative coronary angiography (QCA) is of limited value for the characterization of the functional severity of coronary artery narrowing especially at intermediate degrees of stenosis and thus has been recognized as a poor indicator of functionally significant CAD when compared with pressure-derived fractional flow reserve (FFR). 16, 17 Consequently, the objectives of the present dual-centre study were: (i) to evaluate the diagnostic performance of dynamic 3D-CMR perfusion for the detection of functionally significant CAD as defined by FFR, (ii) to relate the volume of myocardial hypoenhancement to the extent and anatomical localization of the disease, and (iii) to assess the inter-study reproducibility of stress inducible 3D-CMR hypoperfusion.
Methods

Study population
The present prospective study was conducted at two centres (University Hospital Zurich, Switzerland, and University Hospital RWTH Aachen, Germany). A total of 120 patients (n ¼ 31 from Zurich, n ¼ 89 from Aachen; n ¼ 90 males; mean age 63.7 + 11.9 years, range 42 -90 years) scheduled for diagnostic coronary angiography for the evaluation of known or suspected CAD, but without prior coronary bypass grafting, were consecutively recruited between July 2010 and January 2011. All patients gave written informed consent and the study was approved by the local ethics review boards. Patients were instructed to refrain from caffeine-containing substances 24 h prior to the examination. Patients were not considered for study inclusion if they had typical contraindications for CMR imaging (e.g. incompatible metallic implants and claustrophobia) or administration of adenosine.
In a subgroup of 25 patients, a repeat stress 3D-CMR perfusion examination was performed within 24 h prior to invasive coronary angiography to assess inter-study reproducibility.
Cardiac magnetic resonance study
Cardiac magnetic resonance imaging was performed with the patient in the supine position using a 1.5 T MR scanner (Philips Achieva, Best, The Netherlands). A five-element cardiac synergy coil was used for signal reception and cardiac synchronization was performed with a vector-ECG.
After the acquisition of standard cine scans for the assessment of left ventricular function, 3D-CMR perfusion imaging data were acquired. Adenosine was administered intravenously at a dose of 140 mg/kg/ min under continuous monitoring of heart rate and blood pressure. After at least 3 min of adenosine infusion, 3D-CMR stress first-pass perfusion imaging (i.v. bolus application of 0.1 mmol/kg of a gadolinium-based contrast agent, Magnevist Bayer Schering, Berlin, Germany; injection rate 4.0 mL/s followed by 20 mL saline flush) was performed in short-axis geometry with full left ventricular coverage. After a 10 min waiting period for equilibration of the contrast agent within the myocardium, the identical 3D-CMR perfusion scan was repeated at rest. Finally, following another 10 min waiting period, delayed enhancement (DE) imaging was done in the identical shortaxis geometry with a 3D inversion prepared spoiled gradient-echo sequence.
Three-dimensional cardiac magnetic resonance perfusion imaging technique
The perfusion imaging protocol consisted of a saturation-recovery gradient-echo pulse sequence (TR/TE/flip angle 1.9 ms/0. Visual assessment of dynamic three-dimensional cardiac magnetic resonance perfusion scans Cardiac magnetic resonance examinations were analysed visually by a single observer fully blinded to clinical and angiographic patient data on a dedicated workstation (Extended Work Space, Philips Medical Systems). All short-axis slices with clearly identifiable left ventricular cavity enhancement during contrast agent first-pass and with .75% circumferential left ventricular myocardium were selected. The shortaxis slices were divided into six equally distributed segments and Fractional flow reserve vs. three-dimensional cardiac MR perfusion evaluated visually. Perfusion defects in any segment with ≥25% transmurality persisting for three or more consecutive dynamics not being visible on the rest perfusion scan and in the absence of DE were considered to be pathologic.
Measurement of myocardial ischaemic burden
Quantification of myocardial hypoenhancement was performed in all patients using GT Volume (version 1.3.16, GyroTools, Zurich, Switzerland). For the determination of myocardial hypoenhancement, the single dynamic slice images of the stress perfusion scan showing the maximum extent of regional hypoenhancement during peak signal enhancement of remote myocardium were chosen. In the presence of extensive ischaemia-related hypoenhancement (e.g. high-grade triplevessel disease), the remote myocardium either represented an entire myocardial segment or its subepicardial layer. The observer manually traced left ventricular endo-and epicardial borders in all slices. Segmentation of the left ventricular myocardium was done on a pixel-by-pixel basis by adjusting the signal intensity threshold of .2 standard deviations (SD) below the signal of the remote myocardium, and the area of hypoenhancement was measured. Volumes of total left ventricular myocardium and total myocardial hypoenhancement were calculated using the disk summation method. Myocardial ischaemic burden (MIB) was defined by the volume of hypoenhancement normalized to total left ventricular myocardial volume and expressed in per cent.
In the presence of myocardial scar, the amount was quantified on DE images by manual segmentation based on a signal intensity threshold of .2 SD above the average signal of the remote myocardium and subtracted from the volume of hypoenhancement.
Inter-study reproducibility
In 25 randomly chosen patients, 3D-CMR perfusion imaging was performed twice prior to invasive coronary angiography for the determination of inter-study reproducibility. Evaluation of MIB of repeat examinations was conducted by the same reader following a time period of ≥4 weeks with the reader being fully blinded to clinical and angiographic patient data.
Fractional flow reserve measurements and quantitative coronary angiography
Coronary angiography was performed by standard techniques. At least two orthogonal views of every major coronary vessel and its side branches were acquired. QCA (Philips Inturis CardioView, QCA V3.3, Pie Medical Imaging) was performed off-line by an independent observer being unaware of the results of CMR imaging. FFR was measured using standard methods 17 with a 0.014 in. coronary pressure sensor-tip wire (Volcano Therapeutics, San Diego, CA, USA, and Pressure-Wire Certus, St Jude Medical Systems AB, Uppsala, Sweden) in all vessels with a ≥40% diameter stenosis in two orthogonal views in vessels with ≥2 mm luminal diameter. For the purposes of the study, smaller diameter stenoses were considered non-significant. Coronary lesions with an FFR value of ,0.75 were classified as haemodynamically relevant. Total or subtotal vessel occlusions were assigned an FFR value of 0.5.
Statistical analysis
Statistical data analysis was performed using SPSS for Windows 17.0.0 (2008, Chicago, IL, USA). Continuous variables are expressed as mean + SD; categorical variables are expressed as proportions. The paired Student's t-test was used to assess statistical significance of continuous variables between rest and stress. All tests were two tailed; P , 0.05 was considered significant. To determine the cut-off value of MIB being predictive of the presence or absence of significant coronary artery disease as defined by FFR , 0.75, receiver-operator characteristic (ROC) curve analysis was performed and the area under the curve was calculated. Sensitivity and specificity with corresponding 95% confidence intervals (95% CI) were calculated according to standard definitions. In addition, the Bland -Altman analysis was carried out to assess the inter-study reproducibility. To address clustering of territories within patients, linear regressions with MIB as a dependent variable and robust standard error with patient ID as a cluster were performed. Independent variables were dummy variables for ischaemic vs. non-ischaemic territories and for distal, medial, proximal, and side branch territory, respectively, Stata 11.2 (StataCorp, College Station, TX, USA) was used.
Results
Patient characteristics
All 120 patients successfully completed the CMR protocol and the invasive procedures and constituted the final population for data analysis. Tables 1 and 2 provide the clinical baseline characteristics of the patient population and the haemodynamic data recorded during the CMR examination, respectively.
Diagnostic performance
The prevalence of CAD as defined by FFR , 0.75 was 57.5% (69 of 120 patients). Fractional flow reserve vs. three-dimensional cardiac MR perfusion
Assessment of myocardial ischaemic burden
In all patients MIB averaged to 13.8 + 17.2% (range, 0 -79.2%). The mean MIB per coronary territory with and without haemodynamically significant stenosis as defined by FFR is displayed in Figure 4A .
The relation between lesion localization within the coronary arterial tree (i.e. proximal, medial, distal, or side branch stenosis) and the corresponding amount of MIB is illustrated in Figure 4B and confirmed the gradual increase in MIB with more proximal lesion location. In order to identify the amount of MIB leading to most accurate identification of FFR-defined coronary artery disease, ROC analysis was carried out and revealed an MIB cut-off value of 4.4% with a sensitivity and specificity of 85.5 and 86.3%, respectively ( Figure 5 ).
Inter-study reproducibility of myocardial ischaemic burden
Inter-study reproducibility of MIB measurements showed a high correlation (Pearson's correlation coefficient, 0.98, P , 0.0001) and substantial concordance [Lin's correlation coefficient, 0.98 (95% CI: 0.96-0.99)]. The Bland-Altman plot is shown in Figure 6 ; the mean bias for inter-study measurements was 3.0 + 1.4% (95% CI: 2.4 -3.6). 
Discussion
The present study evaluated the diagnostic performance and interstudy reproducibility of 3D-CMR perfusion for the detection of functionally significant CAD as defined by FFR measurements. The main findings of the study were as follows: (i) 3D-CMR perfusion imaging at 1.5 T was successfully performed in a large, consecutive patient population in two independent cardiology departments; (ii) the diagnostic accuracy of 3D-CMR perfusion imaging was high and within the range of previously published data on 2D multislice CMR perfusion imaging using FFR as the Fractional flow reserve vs. three-dimensional cardiac MR perfusion reference standard 18 -20 ; (iii) the diagnostic accuracy was equally high in patients with single-and multi-vessel coronary artery disease; (iv) the amount of MIB gradually increased with more proximal anatomical localization of coronary lesions; and (v) MIB measurement showed high inter-study reproducibility.
The present dual-centre 3D-CMR perfusion study with FFR as the standard of reference yielded similar sensitivity but improved specificity (90 vs. 92% and 82 vs. 74%, respectively) compared with previously published data on 3D-CMR perfusion using angiographic stenosis quantification as the standard of reference. 15 The improved specificity may have been due to a lower rate of falsepositive examinations of intermediate degrees of coronary luminal narrowing on QCA, which are not functionally flow limiting. The diagnostic performance of 3D-CMR perfusion encountered in the current study was similar to previous smaller single-centre studies comparing conventional 20 and high-resolution 18 2D multislice CMR perfusion against FFR measurements (reported sensitivity of 91 and 82% and specificity of 94 and 94%, respectively). confidence intervals for coronary arteries with and without haemodynamically significant stenosis as defined by fractional flow reserve. Differences between groups were statistically significant (P , 0.001). (B) Error bar charts of myocardial ischaemic burden per coronary territory according to the location of a haemodynamically significant stenosis in the coronary arterial tree as defined by fractional flow reserve. Differences between groups were statistically significant (P , 0.001).
Figure 5
Receiver-operator characteristic analysis to determine the cut-off value of myocardial ischaemic burden being predictive of the presence or absence of significant coronary artery disease as defined by fractional flow reserve ,0.75. A cut-off value of myocardial ischaemic burden ¼ 4.4% resulted in a sensitivity and specificity of 85.5 and 86.3%, respectively. AUC, area under the curve. A key advantage of 3D-CMR perfusion imaging over 2D acquisition techniques relates to the volumetric assessment of MIB with a high inter-and intra-reader reproducibility. 15 The high inter-study reproducibility of 3D-CMR perfusion demonstrated in the present study further corroborated its robustness and clinical potential to monitor disease progression or the effectiveness of anti-ischaemic therapeutic strategies. Of note, the inter-study reproducibility of MIB was within the range of previously published data on nuclear perfusion imaging (3.0 vs. 7.2%). 21 In addition, the high reproducibility may result in a lower number of patients needed to achieve sufficient statistical power in anti-ischaemic trials. 22 According to the current guidelines, the decision to perform coronary revascularization procedures should be based on an objective documentation of myocardial ischaemia preferably together with its anatomical localization and amount. Three-dimensional CMR perfusion imaging proved useful to derive such information since MIB and coronary stenosis localization/distribution were readily available. Knowingly, proximal coronary artery disease confers a worse cardiac prognosis. In addition, the amount of myocardial ischaemia has been successfully employed to guide treatment decisions: revascularization has been recommended in the case of an MIB exceeding 10% 6 of the total left ventricular myocardium, but these cut-off values were derived from myocardial nuclear studies. 7, 8 Whether a similar cut-off value may apply to 3D-CMR perfusion imaging is currently unknown and shall be addressed in future studies. Recently, the invasive assessment of the functional significance of coronary lesions has become the cornerstone of therapeutic decision-making, 23, 24 though FFR measurements are invasive, timeconsuming, and associated with radiation exposure rendering the method less attractive for serial assessments. Finally, 3D-CMR perfusion imaging may be considered a noninvasive approach to stratify patients according to guidelines before coronary angiography and therefore might reduce unnecessary invasive diagnostic examinations.
Study limitations
Myocardial ischaemic burden as defined by 3D-CMR perfusion does not provide a measure of quantitative myocardial blood flow but rather represents a snapshot of relative myocardial perfusion distribution at a specific time point during a dynamic perfusion measurement. Consequently, MIB needs to be considered a volumetric measure of per cent ischaemic myocardium in the individual patient and, thus, may be used to assist in adequate treatment selection as recommended by the current guidelines on myocardial revascularization. 6 We found that multi-vessel disease was reliably detected by 3D-CMR stress perfusion which mainly resulted from the inherently high in-plane spatial resolution of the applied 3D-CMR perfusion technique: an overall myocardial signal suppression (so-called 'balanced ischemia') as reported for scintigraphic techniques was not encountered. However, taking into account the relatively low prevalence of multi-vessel disease in the current patient population (13 and 4% for multi-and triple-vessel disease, respectively), future studies are necessary to further research and corroborate this observation.
Finally, in line with the current guidelines and in order to minimize complications of FFR measurements, haemodynamic assessments were only performed in vessels with luminal stenosis of greater than 40% at angiography.
Conclusion
Three-dimensional CMR stress perfusion imaging proved to be highly accurate and reproducible in the evaluation of functionally significant coronary artery disease as defined by FFR. Consequently, 3D-CMR stress perfusion imaging may be regarded as a clinically useful, non-invasive diagnostic tool for stratification of patients with suspected and known coronary artery disease based on the assessment of MIB and lesion localization. Figure 7 Three-dimensional cardiac magnetic resonance adenosine stress perfusion scans during the first and second examination of the same patient for determination of inter-study reproducibility: identical extent of inducible perfusion deficits in anterior/anteroseptal and inferolateral segments can be appreciated (myocardial ischaemic burden of first vs. second examination amounted to 33.6 and 30.2%, respectively).
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